Gregory Flesher
Amministratore Delegato presso RENEO PHARMACEUTICALS, INC.
Patrimonio netto: 38 280 $ in data 30/04/2024
Posizioni attive di Gregory Flesher
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| RENEO PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 09/12/2020 | - |
| Amministratore Delegato | 09/12/2020 | - | |
| Presidente | 09/12/2020 | - | |
| Reneo Pharma Ltd. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Presidente | - | - |
Storia della carriera di Gregory Flesher
Precedenti posizioni note di Gregory Flesher
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ADYNXX, INC. | Direttore/Membro del Consiglio | 22/07/2019 | 01/06/2021 |
| ELEDON PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/05/2017 | 04/09/2020 |
| Amministratore Delegato | 01/05/2017 | 04/09/2020 | |
| Presidente | 01/05/2017 | 06/11/2017 | |
Otic Pharma Ltd.
 Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Direttore/Membro del Consiglio | 27/07/2015 | 01/05/2017 |
| Amministratore Delegato | 27/07/2015 | 01/05/2017 | |
| AVANIR PHARMACEUTICALS INC | Corporate Officer/Principal | 17/02/2011 | 01/01/2015 |
| INTERMUNE INC | Vendite & Marketing | 01/01/2002 | 01/01/2006 |
Formazione di Gregory Flesher
| Purdue University | Undergraduate Degree |
| The Indiana University School of Medicine | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
| Regno Unito | 2 |
Posizioni
| Director/Board Member | 5 |
| Chief Executive Officer | 4 |
| President | 3 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| RENEO PHARMACEUTICALS, INC. | Health Technology |
| ELEDON PHARMACEUTICALS, INC. | Health Technology |
| ADYNXX, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Avanir Pharmaceuticals, Inc.
 Avanir Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Avanir Pharmaceuticals, Inc. engages in the development of therapeutic products for the treatment of nervous system disorder. The company was founded on August 31, 1988 and headquartered in Aliso Viejo, CA. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Otic Pharma Ltd.
Otic Pharma Ltd. Pharmaceuticals: MajorHealth Technology Otic Pharma Ltd. develops and manufactures pharmaceutical products for ear indications. Its products include FoamOtic Externa, FoamOtic Sinus, Foam-O-Vet, and FoamOtic Media. The company was founded by Gad Riesenfeld, Rodrigo A. Yelin and Eran Eilat in March 2008 and is headquartered in Irvine, CA. | Health Technology |
| Reneo Pharma Ltd. |
- Borsa valori
- Insiders
- Gregory Flesher
- Esperienza
